loadpatents
name:-0.020602941513062
name:-0.0081279277801514
name:-0.0070440769195557
ZENDER; LARS Patent Filings

ZENDER; LARS

Patent Applications and Registrations

Patent applications and USPTO patent grants for ZENDER; LARS.The latest application filed is for "treatments of non-alcoholic steatohepatitis (nash)".

Company Profile
8.8.22
  • ZENDER; LARS - ROTTENBURG DE
  • Zender; Lars - Braunschweig DE
  • Zender; Lars - Rottenburg - Wendelsheim DE
  • Zender; Lars - Hannover DE
  • Zender; Lars - Cold Spring Harbor NY
  • Zender; Lars - Huntington NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Treatments Of Non-alcoholic Steatohepatitis (nash)
App 20210213042 - HEIKENWALDER; MATHIAS ;   et al.
2021-07-15
Treatments of non-alcoholic steatohepatitis (NASH)
Grant 11,052,102 - Heikenwalder , et al. July 6, 2
2021-07-06
Medicament For Treatment Of Liver Cancer
App 20200000787 - Zender; Lars ;   et al.
2020-01-02
Radiolabeled Beta-galactosidase Substrate For Pet Imaging Of Senescence
App 20190381198 - Cotton; Jonathan ;   et al.
2019-12-19
Medicament for treatment of liver cancer
Grant 10,441,577 - Zender , et al. Oc
2019-10-15
Treatments Of Non-alcoholic Steatohepatitis (nash)
App 20190262379 - HEIKENWALDER; Mathias ;   et al.
2019-08-29
Medicament For Liver Regeneration And For Treatment Of Liver Failure
App 20190099453 - Zender; Lars ;   et al.
2019-04-04
Medicament For Liver Regeneration And For Treatment Of Liver Failure
App 20190091265 - Zender; Lars ;   et al.
2019-03-28
Medicament for liver regeneration and for treatment of liver failure
Grant 10,188,682 - Zender , et al. Ja
2019-01-29
Medicament For Liver Regeneration And For Treatment Of Liver Failure
App 20160022742 - Zender; Lars ;   et al.
2016-01-28
Medicament for liver regeneration and for treatment of liver failure
Grant 9,186,381 - Zender , et al. November 17, 2
2015-11-17
Medicament For Treatment Of Liver Cancer
App 20150079154 - Zender; Lars ;   et al.
2015-03-19
Medicament For Liver Regeneration And For Treatment Of Liver Failure
App 20140141510 - Zender; Lars ;   et al.
2014-05-22
Compositions For Generating An Antigen Specific Immune Response
App 20120251579 - Zender; Lars
2012-10-04
Orthotopic and genetically tractable non-human animal model for liver cancer and the uses thereof
Grant 8,137,907 - Zender , et al. March 20, 2
2012-03-20
Cooperating Oncogenes In Cancer
App 20110035814 - Zender; Lars ;   et al.
2011-02-10
Methods For Treating Fibrosis By Modulating Cellular Senescence
App 20100310504 - Lowe; Scott W. ;   et al.
2010-12-09
Tumor Suppressor Gene Screening Using Rna Interference Libraries And Method Of Treatment
App 20100297010 - Bric; Anka ;   et al.
2010-11-25
ONCOGENOMICS-BASED RNAi SCREEN AND USE THEREOF TO IDENTIFY NOVEL TUMOR SUPPRESSORS
App 20100273660 - Zender; Lars ;   et al.
2010-10-28
Role of FGF-20 in cancer diagnosis and treatment
Grant 7,794,941 - Powers , et al. September 14, 2
2010-09-14
Orthotopic and genetically tractable non-human animal model for liver cancer and the uses thereof
App 20090029872 - Zender; Lars ;   et al.
2009-01-29
Orthotopic, controllable, and genetically tractable non-human animal model for cancer
App 20090022685 - Lowe; Scott W. ;   et al.
2009-01-22
Role of FGF-20 in cancer diagnosis and treatment
App 20080188434 - Powers; Scott ;   et al.
2008-08-07
Development and use of a new orthotopic, genetically tractable non-human animal model for liver cancer
App 20060162000 - Zender; Lars ;   et al.
2006-07-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed